Improving genetic medicine for ethnic minorities
Part of Genetic & congenital clinical trials.
This trial aims to make genetic medicine better for people from ethnic minority groups. It will ask adults about their views to help improve healthcare for everyone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You can understand and agree to take part.
- You do not have a serious mental health condition.
- You do not have a learning disability.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial explores how genetic information can improve supportive care for people with incurable, life-limiting conditions. It aims to tailor treatments to reduce symptoms based on your DNA.
This study looks at cancer-related inherited gene changes using blood samples. It may help patients and doctors understand cancer risk and guide treatment planning, especially across different ethnic communities.
This trial looks for gene changes that may explain rare conditions, even when the diagnosis is not fully understood. It may help families who have a rare condition or who are related to someone with one.
This study tests a new way to offer genetic testing to young adults (ages 18-39) who have or had cancer. The goal is to make it easier for you to learn if you have inherited gene changes that could affect your cancer and your family's health.
This trial tests whether a “point-of-care” computer tool can help clinicians use a person’s genetic information to choose safer, better medication decisions. It focuses on helping reduce treatment differences for African American patients.
This study uses genetic testing to learn more about the causes of health conditions in Amish and Mennonite people. It may help researchers understand patterns in this community and improve future care.
Hear when a new Genetic Testing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.